News – Page 70 – Endpoints News

'It's the biology, stupid': Relation and GSK team up on fibrosis, osteoarthritis

6 months ago

Trump elevates disproven link between vaccines and autism, saying ‘something is going on’

6 months ago

Supreme Court declines to take PhRMA-Arkansas 340B case

6 months ago

Police arrest person of interest in connection with killing of UnitedHealthcare CEO

6 months ago

Belharra Therapeutics sticks with lead programs, trims workforce by 40%

6 months ago

Agios' stock drops after disclosing new liver-related safety warning in filing to FDA

6 months ago

Exclusive: Vijay Pande hands a16z biotech leadership to Vineeta Agarwala, moves to AI role

6 months ago

GSK reports Blenrep overall survival data in multiple myeloma as it plots market reentry

6 months ago

ICER finds Vertex's non-opioid pain treatment could bring cost savings at a lower price

6 months ago

AbbVie, Genmab tout Epkinly combos in earlier lines of non-Hodgkin lymphoma

6 months ago

AbbVie declares third Phase 3 Parkinson’s win from Cerevel takeover

6 months ago

Merck's Keytruda combo misses overall survival in Phase 3 trial in ovarian cancer

6 months ago

Some research shows patients don’t stick with GLP-1s for long. Amazon Pharmacy and Ro say they're changing that

6 months ago

Enanta's mid-stage win in pediatric RSV; Carisma to lay off 34% of staff

6 months ago

Dimension nabs $500M second fund for 'still contrary' intersection of bio and machine learning

6 months ago

ADC scientist who paved the way for Daiichi’s Enhertu dies

6 months ago

Dutch biotech nabs €85M to position inflammatory antibody for a pharma buyer

6 months ago

Beam shares results from seven patients who received gene-edited sickle cell therapy

6 months ago

AstraZeneca reveals first clinical data for bispecific T cell engager from TeneoTwo buyout

6 months ago

Biosecure bill is left out of end-of-year defense package, dealing blow to chances

6 months ago

Lilly beats Novo in weight loss; Apogee plots Dupixent challenge; Biosecure compromise coming?; and more

6 months ago

BioAge Labs scraps Phase 2 obesity trial just months after IPO

6 months ago

Insurance executive killing puts spotlight on security measures at JP Morgan meeting

6 months ago

European Commission greenlights $16.5B Novo-Catalent acquisition

6 months ago

First page Previous page 67 68 697071 72 73 Next page Last page